Skip to Content

C3 (Rubraca 300 mg)

Generic Name: rucaparib

Pill with imprint C3 is Yellow, Elliptical / Oval and has been identified as Rubraca 300 mg. It is supplied by Clovis Oncology, Inc..

Rubraca is used in the treatment of ovarian cancer; prostate cancer and belongs to the drug class PARP inhibitors. Rubraca 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C3

Rubraca 300 mg C3

Rubraca

Generic Name
rucaparib
Imprint
C3
Strength
300 mg
Color
Yellow
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
PARP inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Clovis Oncology, Inc.
National Drug Code (NDC)
69660-0203
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, silicon dioxide, magnesium stearate, titanium dioxide, magnesium silicate, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C3"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.